ArticleJournal of clinical medicine2022

Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study.

Hideto Kawaratani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.